Peter J. Skoutelas

As the chief business officer, Peter is responsible for establishing and executing Frontier’s business development strategy which includes identifying target customers and managing the execution of the company’s sales strategy.  Peter is also responsible for identifying opportunities for business growth and creating business partnerships, along with overseeing the activities and performance of the business development team.


Prior to joining Frontier, Peter started the Contract Manufacturing business for Pharmascience in Montreal. He built their US division for over 6 years and is credited for growing that new business vertical to over $200M. Pharmascience is a full service CMO specializing in development and manufacturing of complex oncology injectables.


Peter has over 15 years of experience in the Pharmaceutical industry. His experience spans from preclinical development, to API sales, to Generic injectable manufacturing. He began his career in preclinical safety pharmacology where he lead the business development unit for Huntington Life Sciences in Princeton NJ. Gradually, he worked his way into the Clinical Trial sector and took up a Director of Business Development role for AIT Biosciences in Indianapolis. He later spent 5 years in the API industry and began MSN Pharma’s first US office in Edison NJ.

He received his undergraduate degree from The University of California Irvine in Biology and a Masters Degree in Biotechnology from The University of Pennsylvania (UPENN).